Clinical Trials on HER2-positive Recurrent/Metastatic Breast Cancer in China
Total 447 results
-
Peking Union Medical College HospitalTaizhou EOC Pharma Co., Ltd.UnknownHER2-positive Breast CancerChina
-
Hebei Medical University Fourth HospitalRecruitingAdvanced Breast Cancer | HER2-positive Breast CancerChina
-
Fudan UniversityRecruitingHER2-positive, Metastatic Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-positive Breast CancerChina
-
Xijing HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Fudan UniversityRecruitingHER2 Positive Early Breast CancerChina
-
Tianjin Medical University Cancer Institute and...CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerChina
-
Peking Union Medical College HospitalRecruitingHER2-positive Breast Cancer | Early-stage Breast CancerChina
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingER-Positive, HER2-Negative Breast CancerChina
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
DualityBio Inc.BioNTech SERecruiting
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
Daiichi Sankyo, Inc.Completed
-
Second Affiliated Hospital, School of Medicine,...RecruitingHER2-positive Breast Cancer | Adjuvant TherapyChina
-
Tianjin Medical University Cancer Institute and...RecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Shanghai Proton and Heavy Ion CenterRecruitingTriple Negative Breast Cancer | HER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2 Positive | Combination ChemotherapyChina
-
Hunan Cancer HospitalCompletedBreast Neoplasms | HER2-positive Breast CancerChina
-
Ruijin HospitalRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Shenzhen Yangli Pharmaceutical Technology Co., LtdRecruitingMetastatic Breast Cancer | ER+, HER2- Advanced Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive,HER2-negative in Advanced Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingBreast Cancer | HER2-positive Breast Cancer | Circulating Tumor DNA | NeoadjuvantChina
-
Peking UniversityRecruitingHER2-positive Breast Cancer | Triple-negative Breast CancerChina
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.RecruitingLocally Advanced Breast Cancer | Hormone Receptor Positive，HER2-negative Breast CancerChina
-
Tongji HospitalRecruiting
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast CancerChina
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Liaoning Tumor Hospital & InstituteUnknownStage IIIB, IV, Recurrent, and Metastatic Breast CancerChina
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Jiangxi Provincial Cancer HospitalRecruitingHER2-positive Metastatic Breast CancerChina